Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma.

Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma.

Item
http://www.wikidata.org/entity/Q44558771
Bayesian joint selection of genes and pathways: applications in multiple myeloma genomicsTargeting paraprotein biosynthesis for non-invasive characterization of myeloma biology.The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome.Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy.Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma PatientsBiologic frontiers in multiple myeloma: from biomarker identification to clinical practice.Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse.End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma.Audit of Use and Overuse of Serum Protein Immunofixation Electrophoresis and Serum Free Light Chain Assay in Tertiary Health Care: A Case for Algorithmic Testing to Optimize Laboratory Utilization.Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma.Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ RatioPredictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients.Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens
P2860

Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma.

Item
http://www.wikidata.org/entity/Q44558771
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Normalization of free light ch ...... atients with multiple myeloma.
@en
Normalization of free light ch ...... atients with multiple myeloma.
@nl
type
label
Normalization of free light ch ...... atients with multiple myeloma.
@en
Normalization of free light ch ...... atients with multiple myeloma.
@nl
prefLabel
Normalization of free light ch ...... atients with multiple myeloma.
@en
Normalization of free light ch ...... atients with multiple myeloma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Normalization of free light ch ...... atients with multiple myeloma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698